These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 39167221)

  • 21. A Cross-sectional Survey of Public Knowledge and Perspective on Coronavirus Disease, Vaccination, and Related Research in India during the COVID-19 Pandemic.
    Munshi R; Maurya M
    J Assoc Physicians India; 2023 Sep; 71(9):19-27. PubMed ID: 38700297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026.
    Global Burden of Disease 2021 Health Financing Collaborator Network
    Lancet Glob Health; 2023 Mar; 11(3):e385-e413. PubMed ID: 36706770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pandemic preparedness and response: beyond the Access to COVID-19 Tools Accelerator.
    Saxena A; Baker BK; Banda A; Herlitz A; Miller J; Karrar K; Fleurbaey M; Chiwa E; Atuire CA; Hirose I; Hassoun N
    BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36650015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics.
    Martin R; Maleche A; Gay J; Fatima H
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38167259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
    Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
    Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities.
    Scarnà T; Menozzi-Arnaud M; Friede M; DeMarco K; Plopper G; Hamer M; Chakrabarti A; Gilbert PA; Jarrahian C; Mistilis J; Hesselink R; Gandrup-Marino K; Amorij JP; Giersing B
    Expert Opin Drug Deliv; 2023 Mar; 20(3):315-322. PubMed ID: 36649573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opportunities to accelerate immunization progress in middle-income countries.
    Zhu J; Cole CB; Fihman J; Adjagba A; Dasic M; Cernuschi T
    Vaccine; 2024 Apr; 42 Suppl 1():S98-S106. PubMed ID: 37460357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries.
    Peacocke EF; Heupink LF; Frønsdal K; Dahl EH; Chola L
    BMJ Open; 2021 Sep; 11(9):e049505. PubMed ID: 34593496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leveraging lessons from the COVID-19 pandemic to strengthen low-income and middle-income country preparedness for future global health threats.
    Alakija A
    Lancet Infect Dis; 2023 Aug; 23(8):e310-e317. PubMed ID: 37290474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future.
    Pilkington V; Keestra SM; Hill A
    Front Public Health; 2022; 10():821117. PubMed ID: 35321196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa.
    Bright B; Babalola CP; Sam-Agudu NA; Onyeaghala AA; Olatunji A; Aduh U; Sobande PO; Crowell TA; Tebeje YK; Phillip S; Ndembi N; Folayan MO
    Global Health; 2021 Mar; 17(1):24. PubMed ID: 33658050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Financing pandemic prevention, preparedness and response: lessons learned and perspectives for future.
    Ndembi N; Dereje N; Nonvignon J; Aragaw M; Raji T; Fallah MP; Abdulaziz M; Djoudalbaye B; Aluso A; Boum Ii Y; Mwaba G; Shisana O; Ngongo N; Kaseya J
    Global Health; 2024 Aug; 20(1):65. PubMed ID: 39169389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
    Forman R; Shah S; Jeurissen P; Jit M; Mossialos E
    Health Policy; 2021 May; 125(5):553-567. PubMed ID: 33820678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mathematical modelling of the 100-day target for vaccine availability after the detection of a novel pathogen: A case study in Indonesia.
    Bilgin GM; Munira SL; Lokuge K; Glass K
    Vaccine; 2024 Aug; 42(21):126163. PubMed ID: 39060201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa.
    Hassan MA; Aliyu S
    Int J Health Serv; 2022 Jul; 52(3):323-329. PubMed ID: 35469499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current and future nanoparticle vaccines for COVID-19.
    Vu MN; Kelly HG; Kent SJ; Wheatley AK
    EBioMedicine; 2021 Dec; 74():103699. PubMed ID: 34801965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral epidemic preparedness: a perspective from five clinical microbiology laboratories in Europe.
    Martínez MJ; Cotten M; Phan MVT; Becker K; Espasa M; Leegaard TM; Lisby G; Schneider UV; Casals-Pascual C
    Clin Microbiol Infect; 2024 May; 30(5):582-585. PubMed ID: 37119988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Causes and costs of global COVID-19 vaccine inequity.
    Ferranna M
    Semin Immunopathol; 2024 Jan; 45(4-6):469-480. PubMed ID: 37870569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023.
    Lazarus JV; White TM; Wyka K; Ratzan SC; Rabin K; Larson HJ; Martinon-Torres F; Kuchar E; Abdool Karim SS; Giles-Vernick T; Müller S; Batista C; Myburgh N; Kampmann B; El-Mohandes A
    Nat Med; 2024 Jun; 30(6):1559-1563. PubMed ID: 38684861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.